Lumea, a U.S. leader in digital pathology and clinical diagnostic solutions, today announced the integration of Nonagen Bioscience’s Oncuria® suite of bladder cancer tests into Lumea’s comprehensive digital diagnostics platform….
LEHI, UT, UNITED STATES, September 1, 2026 – Lumea, a U.S. leader in digital pathology solutions, and TreatmentGPS, a physician-built AI platform for clinical decision support and patient education, today…
Company Recognized for Large Revenue Growth, Earning a Place Among the Nation’s Most Successful Independent Businesses LEHI, UT, UNITED STATES, August 11, 2026 /EINPresswire/ — Lumea today announced it has…
We are thrilled to announce that we received a global award for exception achievement from the international awards program The Global Recognition Awards™. We couldn’t be prouder of our team…
Recognition places Lumea among elite global winners including Medtronic and Thermo Fisher Scientific in one of digital health’s most competitive annual programs LEHI, UT, UNITED STATES, May 14, 2026 /…
Inaugural DDx Summit Educational Series to Focus on Urology and Prostate Cancer, Uniting Innovators for an Immersive 24-Hour Program LEHI, UT, UNITED STATES, April 22, 2026 — The Digital Diagnostic Summit…
